Fibromyalgia Trial, Recruiting NCT07228897 Sponsor: Ankara Etlik City Hospital Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07228897
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between the ages of 25 and 55
  • You are female
  • You have not done regular physical activity in the past 3 months
  • You have been taking the same medication (such as amitriptyline, duloxetine, milnacipran, pregabalin, or cyclobenzaprine) for at least 1 month before the study starts
  • You are willing to take part in the study voluntarily
  • You are able to use a smartphone app comfortably (confirm with trial site)
  • You agree to allow your personal data to be used in line with the study's data protection policy

Who may not be able to join:

  • You have a history of heart or lung disease
  • Your medication changes at any point during the study
  • You have had injection-based treatments (such as ozone therapy, neural therapy, or acupuncture) in the past 3 months or during the study
  • You have a history of a rheumatological (joint or autoimmune) disease
  • You are currently pregnant or breastfeeding
  • You have a history of cancer
  • You have a psychiatric or neurological condition

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03127970000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ankara Etlik City Hospital
Registry
ClinicalTrials.gov
Start date
5 December 2025
Est. completion
1 November 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

6-minute walk test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov